Cargando…
Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options
SIMPLE SUMMARY: Adrenocortical carcinoma is a rare disease for which in silico analysis may help to identify therapy options. Here, we look at the potential of already FDA-approved drugs and therapies in clinical trials based on genes mutated in ACC and genomic alterations known to be targeted by th...
Autores principales: | Hescheler, Daniel Alexander, Hartmann, Milan Janis Michael, Riemann, Burkhard, Michel, Maximilian, Bruns, Christiane Josephine, Alakus, Hakan, Chiapponi, Costanza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179357/ https://www.ncbi.nlm.nih.gov/pubmed/35681700 http://dx.doi.org/10.3390/cancers14112721 |
Ejemplares similares
-
Anaplastic thyroid cancer: genome-based search for new targeted therapy options
por: Hescheler, Daniel Alexander, et al.
Publicado: (2022) -
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis
por: Hescheler, Daniel A., et al.
Publicado: (2021) -
Differentiated Thyroid Cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine Treatment
por: Chiapponi, Costanza, et al.
Publicado: (2023) -
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data
por: Hescheler, Daniel A., et al.
Publicado: (2020) -
Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse
por: Chiapponi, Costanza, et al.
Publicado: (2021)